Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitors.
Hu, H., Wang, X., Chan, G.K., Chang, J.H., Do, S., Drummond, J., Ebens, A., Lee, W., Ly, J., Lyssikatos, J.P., Murray, J., Moffat, J.G., Chao, Q., Tsui, V., Wallweber, H., Kolesnikov, A.(2015) Bioorg Med Chem Lett 25: 5258-5264
- PubMed: 26459208 
- DOI: 10.1016/j.bmcl.2015.09.052
- Primary Citation of Related Structures:  
5DGZ, 5DHJ, 5DIA - PubMed Abstract: 
Pim kinase inhibitors are promising cancer therapeutics. Pim-2, among the three Pim isoforms, plays a critical role in multiple myeloma yet inhibition of Pim-2 is challenging due to its high affinity for ATP. A co-crystal structure of a screening hit 1 bound to Pim-1 kinase revealed the key binding interactions of its indazole core within the ATP binding site ...